Pharmagreen Appoints Tyrell Crosby, a Professional Athlete,

Pharmagreen Appoints Tyrell Crosby, a Professional Athlete,

CARSON CITY, NV, Nov. 29, 2022 (GLOBE NEWSWIRE) — by way of NewMediaWire – Pharmagreen Biotech, Inc., (OTC PINK: PHBI), (“Pharmagreen” or “company“) is happy to announce that Mr. Tyrell Crosby, a skilled NFL participant, has joined the Pharmagreen workforce to be the Honorary Sports Ambassador for Pharmagreen’s NutraMax Genomic Supplement product line. Tyrell will attend rallies, commerce reveals and different scheduled occasions chosen by Pharmagreen and can present his endorsement of NutraMax merchandise on varied on-line social media platforms. As a skilled athlete, Mr. Crosby is keenly conscious of the necessity for thoughts and physique wellness in harm therapy, rehabilitation and restoration on an ongoing foundation.

Nutraceutical dietary supplements have lengthy been a a part of Tyrell’s wellness routine, and Pharmagreen’s NutraMax Genomic Supplement is exactly formulated to assist ongoing well being within the face of the physique and thoughts stresses in everybody’s life, from the high-performance athlete to the person Daily. Pharmagreen’s proprietary mix is exclusive in the marketplace, a dietary complement for the final word thoughts and physique expertise. Nutrigenomics, or dietary genomics, is worried with the connection between vitamins, weight loss program and gene expression. Pharmagreen created this new line of genomic dietary supplements as a result of well being and wellness start on the mobile stage … NutraMax Genomic Supplement will likely be accessible for buy quickly by way of Shopify, Amazon, different third-party on-line shops, and the corporate’s pending on-line retailer .

According to Zion Market Research, the meals business is rising quickly, with gross sales anticipated to succeed in almost $750 billion by 2028, representing a compound annual development fee of 8.8% over the subsequent six years. As the patron information base of the unbelievable well being advantages of medicinal crops and mushrooms continues to broaden, so does the demand for such organically sourced complement merchandise. Pharmagreen is concentrated on creating its product and turning into a worldwide family model in assist of everybody’s on a regular basis well-being.

Pharamagreen is at present manufacturing the primary provide of NutraMax genomic complement enteric capsules in a cGMP-certified manufacturing facility within the U.S. All natural plant and mushroom biomaterials are examined and licensed for contaminant-free content material and a certificates of research is matched with suppliers.

Mr. Tyrell Crosby commented, “Once I had the opportunity to try the NutraMax genomic supplement and made it part of my daily wellness program, I knew Pharmagreen was on to something great. Nutraceutical products are very important supplements for all serious athletes regarding their performance and daily balance of body and mind. That’s what I get with NutraMax and I’m excited to be involved with Pharmagreen to help the company grow its business.”

Mr. Ethan Styles, Pharmagreen’s VP of Research and Product Development, said: “The NutraMax formulation is designed for the overall well-being of individuals and it gives me great pleasure and satisfaction to hear such an enthusiastic endorsement from a top professional athlete like Tyrell Crosby using our product and experiencing the benefits and spreading the word. Nutrigenomics is an emerging and fascinating science at the cutting edge of our knowledge of human health, and I am truly excited to bring these unique combinations to market.”

Peter Wojcik, CEO of Pharmagreen, stated: “Our partnership with Tyrell Crosby, a professional athlete dedicated to his health and well-being, as well as the well-being of others, is a great opportunity for our product to be represented by an ambassador of brand conscious and knowledgeable. . Hearing Tyrell talk about how NutraMax helps him with his wellness has been a validating experience for our team as we develop nutrigenomic products designed to bring balance and health to people’s lives. We are very excited to be launching this product with Tyrell’s help and approval.”

About Pharmagreen Biotech, Inc.

Pharmagreen is at present creating its nutraceutical merchandise and is concentrated on near-term income from its proprietary mix of therapeutic herbs and fungi, a nutraceutical well being product. Leveraging the corporate’s experience in plant and fungal genetics, Pharmagreen’s transgenic program makes use of the newest know-how accessible to analysis and create every day dietary dietary supplements that assist assist the thoughts and physique. For extra info on the Company and our up to date web site, please go to

Safe Harbor Statement

This press launch comprises forward-looking statements. Such forward-looking statements are topic to a variety of dangers, assumptions and uncertainties that would trigger the Company’s precise outcomes to vary materially from these anticipated in such forward-looking statements. In explicit, elements that would trigger precise outcomes to vary materially from these in future statements embody: our lack of ability to acquire extra financing on acceptable phrases; we danger that our services is not going to acquire widespread market acceptance; lack of ability to compete with others providing comparable merchandise; the failure of our know-how; infringement of our know-how with the proprietary rights of third events; lack of ability to reply to buyer requests; the lack to switch essential clients; the seasonal nature of our enterprise. Forward-looking statements communicate solely as of the date made and aren’t ensures of future efficiency. We undertake no obligation to publicly replace or revise any forward-looking statements. When used on this doc, the phrases “believe”, “expect”, “anticipate”, “estimate”, “project”, “plan”, “should”, “aim”, “may”, “will”, “will ,” “potential” and comparable expressions could also be used to establish forward-looking statements.

OTC Markets or some other securities regulatory authority has not reviewed and accepts no accountability for the adequacy or accuracy of this press launch that has been ready by administration.

Contact info:
Tel: (702) 803 9404
Email: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *